Cetuximab Articles


  • Cetuximab intensifies cisplatin-induced testicular toxicity.

    Epidermal growth factor receptor (EGFR) has proliferative properties in the testis. Cetuximab, an anti-EGFR, is administered together with chemotherapy to patients with various types of cancer. This studies aim was to investigate the effect of cetuximab on testicular function.

    Published May 28, 2016
  • Targeting Signaling Transduction Pathways in Bladder Cancer.

    Systemic therapy for urothelial carcinoma (UC) of the bladder has largely revolved around cytotoxic chemotherapy regimens. However, several recent clinical trials have explored the roles of targeted therapies which specifically inhibit signal transduction pathways.

    Published October 20, 2015